Metabolic Disorders: Difference between revisions
Jump to navigation
Jump to search
David Canner (talk | contribs) No edit summary |
No edit summary |
||
| Line 10: | Line 10: | ||
*[[HMG-CoA Reductase]] | *[[HMG-CoA Reductase]] | ||
*[[Molecular_Playground/Human_PPCA|Protective Protein/Cathepsin A (PPCA)]] | *[[Molecular_Playground/Human_PPCA|Protective Protein/Cathepsin A (PPCA)]] | ||
*[[Bacterial thiolase|Thiolase]] | *[[Bacterial thiolase|Thiolase]] | ||
*[[Treatment_of_Gaucher_disease|Treatment of Gaucher Disease]] | *[[Treatment_of_Gaucher_disease|Treatment of Gaucher Disease]] | ||
Latest revision as of 06:32, 16 September 2022
Metabolic Disorders broadly covers illnesses related to faulty carbohydrate metabolism, amino acid metabolism, organic acid metabolism, or lysosomal storage.
Articles in Proteopedia concerning Metabolic Disorders include:
- Acid-beta-glucosidase
- ß-2 Microglobulin
- HMG-CoA Reductase
- Protective Protein/Cathepsin A (PPCA)
- Thiolase
- Treatment of Gaucher Disease
- Velaglucerase
- Velaglucerase Disulfide Connectivity
To view proteins related to Metabolic Disorders which are Structure Index entries see:
To view automatically seeded indices concerning Metabolic Disorders See:
To View FDA Approved Treatments for Metabolic Disorders See: Treatments
To view other Proteopedia pages about diseases & drug targets, See: Pharmaceutical Drug Targets